GlassScriptPhysician profile
Sarah B Fast
NPI 1306868781
$7,485.39
in general payments reported to CMS, 2019-2025
35 companies · $2,247 in 2025
The $2,247 reported for 2025 was more than what 92% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,006 · 2022: $902 · 2023: $1,153 · 2024: $2,177 · 2025: $2,247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,576.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $876.32 | 2024-2025 | Auvelity |
| Lilly USA, LLC | $820.65 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $811.41 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $712.02 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Abbvie INC. | $606.37 | 2021-2025 | |
| Pfizer INC. | $450.00 | 2021-2025 | |
| Glaxosmithkline, LLC. | $312.00 | 2021-2025 | Shingrix, Bexsero, Pediarix |
| Takeda Pharmaceuticals U.S.A., INC. | $303.26 | 2021-2025 | Trintellix |
| Daiichi Sankyo INC. | $241.19 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $214.13 | 2021-2024 | Jardiance |
| Phathom Pharmaceuticals, INC. | $210.70 | 2024 | Voquezna |
| Biohaven Pharmaceutical Holding Company LTD. | $193.91 | 2022 | |
| Abbott Laboratories | $161.14 | 2022-2025 | Freestyle Libre |
| Dexcom, INC. | $150.64 | 2021-2025 | Dexcom G6 Transmitter |
| Biohaven Pharmaceuticals, INC. | $148.41 | 2021 |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Fast listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.